Controversially, when adding a FABP4 inhibitor to a coculture of ovarian cancer cells and adipocytes, lipid accumulation in the cancer cells and adipocyte-mediated invasion were drastically reduced [26]. Here, FABP4 is linked to ovarian carcinoma.